The share price pretty much went back to the pre-webinar price pump.
Fundamentally Lumos is looking in pretty good shape, with likely regular positive news flow from here on in.
Officially the quarterly on ~31st January will tell us whether we are going in the right direction financially. Hopefully the S.P. has already appreciated sufficiently by then.
In August I has posted a valuation around 17c before any news, based on assets and cost for FDA approval costs (before ViraDx approval). Add in positive cash flow and this thing should fly.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.21M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18518 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 4433 | 1 |
View Market Depth
| Last trade - 08.40am 24/06/2025 (20 minute delay) ? |
| LDX (ASX) Chart |
Day chart unavailable